BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $660 | -20.6% | 13,151 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $831 | +24.4% | 13,151 | -11.4% | 0.00% | 0.0% |
Q1 2023 | $668 | +48.8% | 14,851 | +44.9% | 0.00% | +33.3% |
Q4 2022 | $449 | -99.9% | 10,251 | +7.3% | 0.00% | -25.0% |
Q3 2022 | $629,000 | +30.5% | 9,551 | 0.0% | 0.00% | +33.3% |
Q2 2022 | $482,000 | -21.0% | 9,551 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $610,000 | -40.4% | 9,551 | 0.0% | 0.00% | -40.0% |
Q4 2021 | $1,023,000 | -17.4% | 9,551 | -20.7% | 0.01% | -16.7% |
Q3 2021 | $1,239,000 | +16.9% | 12,051 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $1,060,000 | +20.5% | 12,051 | +33.1% | 0.01% | +20.0% |
Q1 2021 | $880,000 | -13.3% | 9,051 | 0.0% | 0.01% | -16.7% |
Q4 2020 | $1,015,000 | +21.0% | 9,051 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $839,000 | -40.6% | 9,051 | -50.0% | 0.01% | 0.0% |
Q2 2020 | $1,412,000 | -52.4% | 18,102 | -52.4% | 0.01% | -83.3% |
Q3 2018 | $2,966,000 | +145.9% | 38,000 | +100.0% | 0.04% | +50.0% |
Q2 2018 | $1,206,000 | – | 19,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |